London, United Kingdom, December 23, 2021 –(PR.com)– Access will be fully online meaning therefore limiting any risk from the omicron variant of Covid-19. This will allow more attendees to join from across the world without having to worry about rules and regulations at the time. The event will deliver the same fantastic content which you will be able to attend and access from the comfort of your computer screen whether you choose to do that from your home or office.

The Conference will explore real world applications of microneedles in drug delivery and strategies for device design while engaging in the latest innovations in device design and formulation with case studies from thought leaders.

The conference will also consider key developments in the transdermal drug delivery field, including the innovations in microneedle technology for a COVID-19 vaccine and opportunities for development in cancer vaccine delivery, advances in…